The North America Digital Patient Monitoring Devices Market is expected to witness market growth of 24.1% CAGR during the forecast period (2024-2031).
The US market dominated the North America Digital Patient Monitoring Devices Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $229.37 billion by 2031. The Canada market is experiencing a CAGR of 25.6% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 25.3% during 2024-2031.
Digital patient monitoring devices are healthcare tools designed to collect, monitor, and transmit real-time patient health metrics data, allowing for continuous or periodic tracking without requiring constant in-person visits to a healthcare facility. These devices encompass a wide range of technology, including wearable sensors, mobile health applications, and connected medical equipment, which help capture critical data such as heart rate, blood pressure, glucose levels, oxygen saturation, temperature, respiratory rate, and even physical activity levels. The data gathered by these devices can be shared with healthcare providers remotely, enabling timely interventions, better-informed treatment decisions, and personalized care.
The digital patient monitoring devices market has emerged as a transformative force in modern healthcare, enabling a shift from traditional, reactive approaches to a more proactive, data-driven model of care. By capturing data on vital signs such as heart rate, blood pressure, oxygen levels, blood glucose, and even physical activity, these devices allow healthcare providers and patients to monitor and manage health conditions effectively from virtually anywhere. The evolution of digital monitoring technology marks a profound change in healthcare, facilitating remote patient management, reducing the need for frequent hospital visits, and empowering individuals to take control of their health.
In Mexico, the increasing prevalence of chronic diseases, especially diabetes, highlights the need for robust digital health solutions. In 2019, Mexico ranked sixth globally for the highest number of adults living with diabetes mellitus, with 12.8 million affected. This figure is expected to rise to 22.3 million by 2045, underscoring an urgent need for digital monitoring devices that support users in managing diabetes and related conditions. These devices are invaluable for tracking glucose levels, medication adherence, and lifestyle factors, which are crucial for managing the country’s growing disease burden. Initiatives like the National Health and Nutrition Survey further support these efforts, raising awareness about lifestyle diseases and encouraging preventive care throughout the population. Consequently, North America presents a significant growth opportunity for expanding the digital patient monitoring devices market as demand intensifies.
The US market dominated the North America Digital Patient Monitoring Devices Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $229.37 billion by 2031. The Canada market is experiencing a CAGR of 25.6% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 25.3% during 2024-2031.
Digital patient monitoring devices are healthcare tools designed to collect, monitor, and transmit real-time patient health metrics data, allowing for continuous or periodic tracking without requiring constant in-person visits to a healthcare facility. These devices encompass a wide range of technology, including wearable sensors, mobile health applications, and connected medical equipment, which help capture critical data such as heart rate, blood pressure, glucose levels, oxygen saturation, temperature, respiratory rate, and even physical activity levels. The data gathered by these devices can be shared with healthcare providers remotely, enabling timely interventions, better-informed treatment decisions, and personalized care.
The digital patient monitoring devices market has emerged as a transformative force in modern healthcare, enabling a shift from traditional, reactive approaches to a more proactive, data-driven model of care. By capturing data on vital signs such as heart rate, blood pressure, oxygen levels, blood glucose, and even physical activity, these devices allow healthcare providers and patients to monitor and manage health conditions effectively from virtually anywhere. The evolution of digital monitoring technology marks a profound change in healthcare, facilitating remote patient management, reducing the need for frequent hospital visits, and empowering individuals to take control of their health.
In Mexico, the increasing prevalence of chronic diseases, especially diabetes, highlights the need for robust digital health solutions. In 2019, Mexico ranked sixth globally for the highest number of adults living with diabetes mellitus, with 12.8 million affected. This figure is expected to rise to 22.3 million by 2045, underscoring an urgent need for digital monitoring devices that support users in managing diabetes and related conditions. These devices are invaluable for tracking glucose levels, medication adherence, and lifestyle factors, which are crucial for managing the country’s growing disease burden. Initiatives like the National Health and Nutrition Survey further support these efforts, raising awareness about lifestyle diseases and encouraging preventive care throughout the population. Consequently, North America presents a significant growth opportunity for expanding the digital patient monitoring devices market as demand intensifies.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- Hoffmann-La Roche AG
- Koninklijke Philips N.V
- Abbott Laboratories
- Boston Scientific Corporation
- OMRON Corporation
- Fitbit, Inc. (Google LLC)
- ResMed, Inc.
Market Report Segmentation
By Product
- Diagnostic Monitoring Devices
- Vital Sign Monitors
- Sleep Monitors
- Fetal Monitors
- Neuromonitors & Other Monitors
- Therapeutic Monitoring Devices
- Insulin Monitors
- Respiratory Monitors
- Other Monitors
By Type
- Wearable Devices
- Wireless Sensor Technology
- mHealth
- Telehealth
- Remote Patient Monitoring
- Hospital Inpatient
- Ambulatory Patient
- Smart Home Healthcare
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Digital Patient Monitoring Devices Market by Product
Chapter 6. North America Digital Patient Monitoring Devices Market by Type
Chapter 7. North America Digital Patient Monitoring Devices Market by Country
Chapter 8. Company Profiles
Companies Mentioned
Some of the leading companies profiled in this North America Digital Patient Monitoring Devices Market report include:- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- F. Hoffmann-La Roche AG
- Koninklijke Philips N.V
- Abbott Laboratories
- Boston Scientific Corporation
- OMRON Corporation
- Fitbit, Inc. (Google LLC)
- ResMed, Inc.
Methodology
LOADING...
